NO744537L - - Google Patents

Info

Publication number
NO744537L
NO744537L NO744537A NO744537A NO744537L NO 744537 L NO744537 L NO 744537L NO 744537 A NO744537 A NO 744537A NO 744537 A NO744537 A NO 744537A NO 744537 L NO744537 L NO 744537L
Authority
NO
Norway
Prior art keywords
formula
compound
preparation
ethylidene
product
Prior art date
Application number
NO744537A
Other languages
Norwegian (no)
Inventor
J P Dusza
H L Lindsay
S Bernstein
R G Child
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US00425421A external-priority patent/US3855276A/en
Priority claimed from US00425422A external-priority patent/US3852334A/en
Priority claimed from US00425420A external-priority patent/US3856838A/en
Priority claimed from US425423A external-priority patent/US3882149A/en
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NO744537L publication Critical patent/NO744537L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/02Compounds containing any of the groups, e.g. carbazates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)

Description

Foreliggende oppfinnelse gjelder fremgangsmåte for fremstilling av nye substituerte karbazinsyrealkylestere som har anvendelse som antivirusforbindelser mot forskjellige rhinovirka. The present invention relates to a method for the production of new substituted carbazine alkyl esters which are used as antiviral compounds against various rhinoviruses.

Spesielt gjelder oppfinnelsen fremgangsmåte for fremstilling av forbindelser med formelen: In particular, the invention relates to the method for producing compounds with the formula:

hvor er hydrogen eller lavere alkyl (C^—), R~er lavere alkyl (C-^-Cg) og X er 2-naftyl, 3-fenantryl, 5-indanyl, 5,6,7,8-tetrahydro-2-haftyl, 2-benzofuranyl, 5-klor-2-benzofuranyl, 3,4-dimetoksybenzyl, 3-etoksy-2-hydroksybenzyl eller 3-bifenyl. where is hydrogen or lower alkyl (C^—), R~ is lower alkyl (C-^-Cg) and X is 2-naphthyl, 3-phenanthryl, 5-indanyl, 5,6,7,8-tetrahydro-2 -haftyl, 2-benzofuranyl, 5-chloro-2-benzofuranyl, 3,4-dimethoxybenzyl, 3-ethoxy-2-hydroxybenzyl or 3-biphenyl.

Fremgangsmåten ifølge oppfinnelsen kan illustreres grafisk som følger: The method according to the invention can be illustrated graphically as follows:

hvor R^, R2og X er som tidligere definert. Blant de spesielle forbindelser som kan fremstilles ved ovenstående fremgangsmåte er eksempelvis: 3-[1-(2-naftyl)etyliden]-karbazinsyre-ety1-ester 3-[1-(2-naftyl)etyliden]-karbazinsyre-metylester, 3-(2-naftylmetylen)-karbazinsyre-etylester, 3-[1-(2-naftyl)etyliden]-karbazinsyre-tertiær-butylester , 3- [ 1- (2-naftyl) etylidenft-■ karbazinsyre-pentylester, 3-[1-(2-naftyl)propyliden]-karbazinsyre-butylester, 3-[1-(3-fenantryl)etyliden]-karbazinsyre-ety1- where R 1 , R 2 and X are as previously defined. Among the special compounds that can be produced by the above method are, for example: 3-[1-(2-naphthyl)ethylidene]-carbazinic acid ethyl ester 3-[1-(2-naphthyl)ethylidene]-carbazinic acid methyl ester, 3- (2-Naphthylmethylene)-carbazinic acid ethyl ester, 3-[1-(2-Naphthyl)ethylidene]-carbazinic acid tert-butyl ester -(2-Naphthyl)propylidene]-carbazinic acid butyl ester, 3-[1-(3-phenanthryl)ethylidene]-carbazinic acid-ethyl-1-

ester , 3-[1-(3-fenantryl)etyliden]-karbazinsyre-metylester, 3-[1-(3-fenantryl)etyliden]-karbazinsyre-propylester, 3-[1-(3-fenantryl)etyliden]-karbazinsyre-t-butylester, 3-[l-(3-fenantryl)etyliden]-karbazinsyre-heksylester, 3-[1-(5-indanyl)-etyliden]-karbazinsyre-etylester, 3-[1-(5,5,7,8-tetrahydro-2-naftyl)etyliden]-karbazinsyre-etylester, 3-[1-(5-indanyl)-etyliden]-karbazinsyre-propylester, 3-[1-(5,6,7,8-tetrahydro-2-naftyl)etyliden]-karbazinsyre-metylester og 3-[1-(5-indanyl)-etyliden]-karbazinsyre-heksylester, 3-[1-(2-benzofuranyl)-etyliden]-karbazinsyre-etylester, 3-[1-(5-klor-2-benzofuranyl)-etyliden]-karbazinsyre-etylester, 3-[1-(5-klor-2-benzofuranyl)-etyliden]-karbazinsyre-propylester, 3-[1-(2-benzofuranyl)-etyliden]-karbazinsyre-t-butylester, 3-(3-etoksysalicyliden)-karbazinsyre-etylester, 3-(a-etylveratryliden)-karbazinsyre-ety lester og 3-[1-(3-bifenyl)etyliden]-karbazinsyre-etylester. ester , 3-[1-(3-phenanthryl)ethylidene]-carbazinic acid methyl ester, 3-[1-(3-phenanthryl)ethylidene]-carbazinic acid propyl ester, 3-[1-(3-phenanthryl)ethylidene]-carbazinic acid -t-Butyl Ester, 3-[1-(3-Phenanthryl)ethylidene]-Carbazic Acid Hexyl Ester, 3-[1-(5-Indanyl)-Ethylidene]-Carbazic Acid Ethyl Ester, 3-[1-(5,5, 7,8-Tetrahydro-2-Naphthyl)ethylidene]-Carbazic Acid Ethyl Ester, 3-[1-(5-Indanyl)-Ethylidene]-Carbazic Acid Propyl Ester, 3-[1-(5,6,7,8-Tetrahydro -2-Naphthyl)ethylidene]-carbazinic acid methyl ester and 3-[1-(5-indanyl)-ethylidene]-carbazinic acid hexyl ester, 3-[1-(2-benzofuranyl)-ethylidene]-carbazinic acid ethyl ester, 3- [1-(5-Chloro-2-benzofuranyl)-ethylidene]-carbazinic acid ethyl ester, 3-[1-(5-chloro-2-benzofuranyl)-ethylidene]-carbazinic acid propyl ester, 3-[1-(2- benzofuranyl)-ethylidene]-carbamic acid t-butyl ester, 3-(3-ethoxysalicylidene)-carbamic acid ethyl ester, 3-(a-ethylveratrylidene)-carbamic acid ethyl ester and 3-[1-(3-biphenyl)ethylidene]- carbamic acid ethyl ester.

Forbindelsene som fremstilles ifølge oppfinnelsen oppviser antivirusaktivitet mot forskjellige rhinovira. Følgende metode anvendes for å bestemme antirhinovirus-aktiviteten for forbindelsene, Sammenflytende enkeltsjikt av en kontinuerlig celle-rekke. som for eksempel "HeLa", "Hep-2", "KB" eller "L-132" som dyrkes i plastskåler med vevkultur, ble infisert med en av de vira som forårsaker luftveisinfeksjoner som for eksempel vanlig forkjølelse. Disse vira innbefatter medlemmer av picornavirusgruppen omfattende rhinovira, eksempelvis typene IB, 2, 5, 14 eller 23 og omfattende enterovira som for eksempel Coxsackie A-15 eller A-21. Beskyttelse av vevene mot den cytopatiske virkning av viraene ble fastslått ved hjelp av en plateinhiberingstest hvor testforbindelsen ble adsorbert på et filterpapirstykke og plassert på den ågar som anvendes som overliggende sjikt på det infiserte cellé-monosjiktet, eller ved innblanding i det nevnte agaroversjiktet. Agaroversjikt-mediet som anvendes for dette formål hadde følgende sammen-setning : The compounds produced according to the invention exhibit antiviral activity against various rhinoviruses. The following method is used to determine the antirhinovirus activity of the compounds, Confluent monolayer of a continuous cell array. such as "HeLa", "Hep-2", "KB" or "L-132" grown in plastic tissue culture dishes, were infected with one of the viruses that cause respiratory infections such as the common cold. These viruses include members of the picornavirus group including rhinoviruses, for example types IB, 2, 5, 14 or 23 and including enteroviruses such as Coxsackie A-15 or A-21. Protection of the tissues against the cytopathic effect of the viruses was determined by means of a plate inhibition test where the test compound was adsorbed on a piece of filter paper and placed on the agar used as an overlying layer on the infected cell monolayer, or by mixing in the aforementioned agar overlay. The agar overlay medium used for this purpose had the following composition:

"Minimum Essential Medium" (Eagles) inneholdende "Earle 's Salts" (Grand Island Biological Company, Grand Island, New York), som ble tilsatt: "Minimum Essential Medium" (Eagles) containing "Earle's Salts" (Grand Island Biological Company, Grand Island, New York), to which was added:

Det virus-infiserte cellemonosjiktet pluss test-forbindelse ble inkubert <i 3 til 5 dager i en fuktig atmosfære med 5 % karbondioksyd ved enten 33 eller 37°C, avhengig av viruset. Disse forbindelsers evne titlZa beskytte vev fra ødeleggelse forårsaket av vira, fremgikk etter farging av de resterende, uinfiserte cellene med 0,5 %-ig krystallfiolett i 20 %-ig etanol. The virus-infected cell monolayer plus test compound was incubated for 3 to 5 days in a humidified atmosphere with 5% carbon dioxide at either 33 or 37°C, depending on the virus. The ability of these compounds to protect tissue from destruction caused by viruses was demonstrated after staining the remaining, uninfected cells with 0.5% crystal violet in 20% ethanol.

En oppsummering av de resultater som er oppnådd i de testede områder er vist i følgende tabell. A summary of the results obtained in the tested areas is shown in the following table.

Følgende eksempler beskriver i detalj fremstilling ifølge oppfinnelsen av representative aktive forbindelser. The following examples describe in detail the preparation according to the invention of representative active compounds.

Eksempel 1Example 1

Fremstilling av 3-[ 1-( 2- naftyl) etyliden]- karbazinsyre- etylester Preparation of 3-[1-(2-naphthyl)ethylidene]-carbamic acid ethyl ester

En blanding av 5,0 g 2-acetonafton, 3,12 g etylkarbazat og 2 dråper konsentrert saltsyre i 100 ml 95 %-ig etanol oppvarmes på tilbakeløp i 1,5 timer og avkjøles så til romtemperatur. Det dannede bunnfall oppsamles ved filtrering, oppløses i metylenklorid og føres gjennom en kolonne med surt magnesiumsilikat. Utløpet fra tilbakeløpskokingen behandles med heksan til krystallisasjon. Produktet oppsamles og tørkes og gir 2,16 g, smeltepunkt 133,5-134,5°C. A mixture of 5.0 g of 2-acetonenaphtho, 3.12 g of ethyl carbazate and 2 drops of concentrated hydrochloric acid in 100 ml of 95% ethanol is heated at reflux for 1.5 hours and then cooled to room temperature. The precipitate formed is collected by filtration, dissolved in methylene chloride and passed through a column of acidic magnesium silicate. The effluent from the reflux is treated with hexane until crystallization. The product is collected and dried to give 2.16 g, melting point 133.5-134.5°C.

Analyse: Beregnet for C]_5Hi5<N>2°2<:><C>' 70'29'H'6'29»N>10,93 Analysis: Calculated for C]_5Hi5<N>2°2<:><C>' 70'29'H'6'29»N>10.93

Funnet : C, 70,14, H, 6,25, N, 10,91. Found: C, 70.14, H, 6.25, N, 10.91.

Eksempel 2Example 2

Fremstilling av 3-[ 1-( 2- naftyl) etyliden]- karbazinsyre- etylester Preparation of 3-[1-(2-naphthyl)ethylidene]-carbamic acid ethyl ester

En blanding av 8,5 g 2-acetonafton og 4,5 g metylkarbazat i 25 ml absolutt etanol inneholdende 2 dråper konsentrert saltsyre oppvarmes under tilbakeløp i 1,5 timer og avkjøles så. Bunnfallet vaskes med heksan og så med vann, tørkes, oppløses i metylenklorid og føres gjennom en kolonne med surt magnesiumsilikat. Tilbakeløpsavløpet behandles med heksan til krystallisasjon. Produktet oppsamles og tørkes, hvorved det oppnås 9,6 g med smeltepunkt 130,5-131,5°C. A mixture of 8.5 g of 2-acetonenaphtho and 4.5 g of methylcarbazate in 25 ml of absolute ethanol containing 2 drops of concentrated hydrochloric acid is heated under reflux for 1.5 hours and then cooled. The precipitate is washed with hexane and then with water, dried, dissolved in methylene chloride and passed through a column of acid magnesium silicate. The reflux effluent is treated with hexane until crystallization. The product is collected and dried, whereby 9.6 g with a melting point of 130.5-131.5°C are obtained.

Analyse: Beregnet for ci4H]_4<N>2°2: C'69'40'H'5,83, N, 11,56 Analysis: Calculated for ci4H]_4<N>2°2: C'69'40'H'5.83, N, 11.56

Funnet : C, 69,24, H, 5,80, N, 11,45. Found: C, 69.24, H, 5.80, N, 11.45.

Eksempel 3Example 3

Fremstilling av 3-( 2- naftylmetylen)- karbazinsyre- etylesterPreparation of 3-(2-naphthylmethylene)-carbamic acid ethyl ester

En blanding av 15 g /3-naftaldehyd og 10,4 g etylkarbazat i 100 ml absolutt etanol inneholdende 2 dråper konsentrert saltsyre oppvarmes på et dampbad i 0,75 time, avkjøles og filtreres. Bunnfallet vaskes med etanol og vann. Bunnfallet oppløses i metylenklorid og føres gjennom én kolonne med surt magnesiumsilikat. Avløpet fra tilbakeløpsoppvarmingen behandles med heksan for å oppnå krystallisasjon. Produktet oppsamles ved filtrering, vaskes med heksan og tørkes. Det oppnås 12,0 g som smelter ved 136,5-137,5°C. A mixture of 15 g of /3-naphthaldehyde and 10.4 g of ethyl carbazate in 100 ml of absolute ethanol containing 2 drops of concentrated hydrochloric acid is heated on a steam bath for 0.75 hour, cooled and filtered. The precipitate is washed with ethanol and water. The precipitate is dissolved in methylene chloride and passed through one column of acidic magnesium silicate. The effluent from the reflux heating is treated with hexane to achieve crystallization. The product is collected by filtration, washed with hexane and dried. 12.0 g is obtained which melts at 136.5-137.5°C.

Analyse: Beregnet for ci4Hi4N2°2: C'69'40'H'5'83, N/11,56 Analysis: Calculated for ci4Hi4N2°2: C'69'40'H'5'83, N/11.56

Funnet : C, 69,26, H, 6,04, N, 11,58. Found: C, 69.26, H, 6.04, N, 11.58.

Eksempel 4Example 4

Fremstilling av 3-[ 1-( 2- naftyl) etyliden]- karbazinsyre- tert.-butylester Preparation of 3-[1-(2-naphthyl)ethylidene]-carbamic acid tert-butyl ester

En blanding av 8,5 g 2-acetonafton og 6,6 g tert.-butylkarbazat i en løsning av 94 ml absolutt etanol og 6 ml iseddik oppvarmes på et dampbad i 2 timer Ipg avkjøles. Bunnfallet oppsamles, oppløses i metylenklorid og føres gjennom en kolonne med surt magnesiumsilikat. Avløpet fra tilbakeløps-oppvarmingeh behandles med heksan for å oppnå krystallisasjon. Produktet oppsamles, vaskes med heksan og tørkes. Det oppnås 8,2 g som smelter ved 178-180°C. A mixture of 8.5 g of 2-acetonenaphtho and 6.6 g of tert-butyl carbazate in a solution of 94 ml of absolute ethanol and 6 ml of glacial acetic acid is heated on a steam bath for 2 hours and cooled. The precipitate is collected, dissolved in methylene chloride and passed through a column of acidic magnesium silicate. The effluent from reflux heating is treated with hexane to achieve crystallization. The product is collected, washed with hexane and dried. 8.2 g is obtained which melts at 178-180°C.

Analyse: Beregnet for ci7<H2>oN2°2<:>C'71,80,H'7'09'N'9,85 Analysis: Calculated for ci7<H2>oN2°2<:>C'71.80,H'7'09'N'9.85

Funnet : C, 72,21, H, 7,38, N, 9,99. Found: C, 72.21, H, 7.38, N, 9.99.

Eksempel 5Example 5

Fremstilling av 3-[ 1-( 3- fenantryl) etyliden]- karbazinsyre- etylester Preparation of 3-[1-(3-phenanthryl) ethylidene]- carbamic acid ethyl ester

En blanding av 4,4 g 3-acetylfenantren, 2,1 g etylkarbazat og 2 dråper konsentrert saltsyre i 100 ml 95 %-ig etanol oppvarmes på et dampbad i 1 time, kjøles til romtemperatur og filtreres. Bunnfallet oppløses i metylenklorid og føres gjennom en kolonne med surt magnesiumsilikat. Avløpet fra tilbakeløps-behandlingen behandles med heksan for å oppnå krystallisasjon. Produktet oppsamles og tørkes. Det oppnås 4,0 g som smelter ved 164-165°C. A mixture of 4.4 g of 3-acetylphenanthrene, 2.1 g of ethyl carbazate and 2 drops of concentrated hydrochloric acid in 100 ml of 95% ethanol is heated on a steam bath for 1 hour, cooled to room temperature and filtered. The precipitate is dissolved in methylene chloride and passed through a column of acidic magnesium silicate. The effluent from the reflux treatment is treated with hexane to achieve crystallization. The product is collected and dried. 4.0 g is obtained which melts at 164-165°C.

Analyse: Beregnet for ClgH18N202: S, 74,49, H, 5,92, N, 9,15 Analysis: Calculated for ClgH18N202: S, 74.49, H, 5.92, N, 9.15

Funnet : C, 74,59, H, 5,91, N, 9,11. Found : C, 74.59, H, 5.91, N, 9.11.

Eksempel 6Example 6

Fremstilling av 3-[ 1-( 3- fenantryl) etyliden]- karbazinsyre- metyl-ester Preparation of 3-[1-(3-phenanthryl)ethylidene]-carbamic acid methyl ester

En blanding av 11,0 g 3-acetylfenantren og 9,0 g metylkarbazat i 50 ml av en løsning av 4 % iseddik i absolutt etanol. oppvarmes under tilbakeløp i 2 timer og avkjøles i et kjøleskap. Bunnfallet vaskes med 95 %-ig etanol og så med vann. Bunnfallet oppløses i metylenklorid og føres gjennom en kolonne med surt magnesiumsilikat. Utløpet fra tilbakeløpsbehandlingen behandles med heksan for å gi krystallisasjon. Produktet oppsamles og tørkes. Det oppnås 12,1 g som smelter ved 176-178,5°C. Analyse: Beregnet for C]_8H16<N>2°2<:><C>' 73,95,H'5,52'N'9,58 A mixture of 11.0 g of 3-acetylphenanthrene and 9.0 g of methylcarbazate in 50 ml of a solution of 4% glacial acetic acid in absolute ethanol. heated under reflux for 2 hours and cooled in a refrigerator. The precipitate is washed with 95% ethanol and then with water. The precipitate is dissolved in methylene chloride and passed through a column of acidic magnesium silicate. The effluent from the reflux treatment is treated with hexane to provide crystallization. The product is collected and dried. 12.1 g is obtained which melts at 176-178.5°C. Analysis: Calculated for C]_8H16<N>2°2<:><C>' 73.95,H'5.52'N'9.58

Funnet : C, 74,05, H, 5,57, N, 9,55. Found: C, 74.05, H, 5.57, N, 9.55.

Eksempel 7Example 7

Fremstilling av 3-[ 1-( 5- indanyl) etyliden]- karbazinsyre- etylester Preparation of 3-[1-(5-indanyl)ethylidene]-carbamic acid ethyl ester

En blanding av 5,7 g 5-acetyliden og 3,18 g etylkarbazat i 200 ml 95 %-ig etanol inneholdende 2 dråper konsentrert saltsyre oppvarmes under tilbakeløp i 1 time og inndampes til tørrhet. Vann tilsettes og det oppstår et krystallinsk fast stoff. Dette faste stoff oppløses i metylenklorid og føres gjennom en kolonne med surt magnesiumsilikat. Utløpet fra tilbakeløpsbehandlingen bela ndles- med heksan slik at krystallisasjon inntrer. Produktet oppsamles og tørkes og gir 6,0 g som smelter ved 109-109,5°C. Analyse: Beregnet for ci4Hi8N2°2<:>C# 68,27, H' 7'37' N' 11'37 A mixture of 5.7 g of 5-acetylidene and 3.18 g of ethyl carbazate in 200 ml of 95% ethanol containing 2 drops of concentrated hydrochloric acid is heated under reflux for 1 hour and evaporated to dryness. Water is added and a crystalline solid is formed. This solid is dissolved in methylene chloride and passed through a column of acidic magnesium silicate. The outlet from the reflux treatment is treated with hexane so that crystallization occurs. The product is collected and dried to give 6.0 g which melts at 109-109.5°C. Analysis: Calculated for ci4Hi8N2°2<:>C# 68.27, H' 7'37' N' 11'37

Funnet : C, 68,54, H, 7,47, N, 11,59. Found: C, 68.54, H, 7.47, N, 11.59.

Eksempel 8Example 8

Fremstilling av 3-[ 1-( 5, 6, 7, 8- tetrahydro- 2- naftyl) etyliden]-karbazinsyre- etylester Preparation of 3-[1-(5,6,7,8-tetrahydro-2-naphthyl)ethylidene]-carbamic acid ethyl ester

En blanding av 8,71 g 6-acetyltetralin og 5,0 g etylkarbazat i 25 ml absolutt etanol inneholdende 2 dråper konsentrert saltsyre oppvarmes under tilbakeløp i 2 timer på dampbad og avkjøles. Bunnfallet oppløses i metylenklorid og føres gjennom en kolonne med surt magnesiumsilikat. Utløpet fra tilbakeløpsbehandlingen behandles med heksan slik at krystallisasjon inntrer. Produktet oppsamles og tørkes og gir A mixture of 8.71 g of 6-acetyltetralin and 5.0 g of ethyl carbazate in 25 ml of absolute ethanol containing 2 drops of concentrated hydrochloric acid is heated under reflux for 2 hours on a steam bath and cooled. The precipitate is dissolved in methylene chloride and passed through a column of acidic magnesium silicate. The effluent from the reflux treatment is treated with hexane so that crystallization occurs. The product is collected and dried and gives

.7,65 g som sme]lter ved 118,5-120°C..7.65 g which melts at 118.5-120°C.

Analyse: Beregnet for ci5<H2>o<N>2°2: C'69'20'H'7'74 >N'IO,76 Analysis: Calculated for ci5<H2>o<N>2°2: C'69'20'H'7'74 >N'IO,76

Funnet : C, 69,40, H, 7,89, N, 10,93. Found: C, 69.40, H, 7.89, N, 10.93.

Eksempel 9Example 9

Fremstilling av 3-[ 1-( 2- benzofuranyl) etyliden]- karbazinsyre-ety lester Preparation of 3-[1-(2-benzofuranyl)ethylidene]-carbamic acid ethyl ester

En blanding av 4,0 g 2-acetylbenzofuran og 4,0 g etylkarbazat i 200 ml av en blanding av 4 % iseddik i absolutt etanol oppvarmes på et dampbad i 2 timer, avkjøles til romtemperatur og filtreres. Bunnfallet oppløses i metylenklorid og føres gjennom en kolonne med surt magnesiumsilikat. Utløpet fra tilbakeløpsoppvarmingen behandles med heksan slik at det inntrer krystallisasjon. Produktet oppsamles og tørkes og gir 3,6 g som smelter ved 173-174°C. A mixture of 4.0 g of 2-acetylbenzofuran and 4.0 g of ethyl carbazate in 200 ml of a mixture of 4% glacial acetic acid in absolute ethanol is heated on a steam bath for 2 hours, cooled to room temperature and filtered. The precipitate is dissolved in methylene chloride and passed through a column of acidic magnesium silicate. The outlet from the reflux heating is treated with hexane so that crystallization occurs. The product is collected and dried to give 3.6 g which melts at 173-174°C.

Analyse: Beregnet for C]_3Hi4N2°3 : c>63'40, H, 5,73, N, 11,38 Analysis: Calculated for C]_3Hi4N2°3 : c>63'40, H, 5.73, N, 11.38

Funnet : C, 63,21, H, 5,83, N, 11,41. Found: C, 63.21, H, 5.83, N, 11.41.

Eksempel 10Example 10

Fremstilling av 3-[ 1-( 5- klor- 2- benzofuranyl) etyliden]- karbazinsyre- ety le ster Preparation of 3-[1-(5-chloro-2-benzofuranyl)ethylidene]-carbamic acid ethyl ester

En blanding av 1,94 g 5-klor-2-acetylbenzofuran, 1,04 g etylkarbazat og 1 dråpe konsentrert HCl i 25 ml 95 %-ig etanol oppvarmes på et dampbad i 1 time, avkjøles og filtreres. Bunnfallet oppløses i metylenklorid og føres gjennom en kolonne med surt magnesiumsilikat. Utløpet fra tilbakeløpsoppvarmingen behandles med heksan slik at det inntrer krystallisasjon. Produktet oppsamles, tørkes og gir 2,5 g som smelter ved 202-203°C. Analyse: Beregnet for ci3H]_3ClN203: C' 55'61'H'4'66'N'9'98»A mixture of 1.94 g of 5-chloro-2-acetylbenzofuran, 1.04 g of ethyl carbazate and 1 drop of concentrated HCl in 25 ml of 95% ethanol is heated on a steam bath for 1 hour, cooled and filtered. The precipitate is dissolved in methylene chloride and passed through a column of acidic magnesium silicate. The outlet from the reflux heating is treated with hexane so that crystallization occurs. The product is collected, dried and yields 2.5 g which melts at 202-203°C. Analysis: Calculated for ci3H]_3ClN203: C' 55'61'H'4'66'N'9'98»

Cl, 12,63 Cl, 12.63

Funnet : C, 56,06, H, 4,73, N, 10,10, Found : C, 56.06, H, 4.73, N, 10.10,

Cl, 12., 39. Cl, 12., 39.

Eksempel 11Example 11

Fremstilling av 3- ( oi- etylveratryl) - karbazinsyre- etylesterPreparation of 3-(o-ethylveratryl)-carbamic acid ethyl ester

En blanding av 5,0 g 3,4-dimetoksypropiofenon, 2,71 g etylkarbazat og 2 dråper konsentrert saltsyre i 100 ml 95 %-ig etanol oppvarmes under tilbakeløp på et dampbad il time. Blandingen avkjøles over natten og inndampes til tørrhet slik at det oppnås en olje. Oljen utgnis med varmt heksan slik at det oppnås et krystallisk produkt. Dette produkt oppløses i metylenklorid og føres gjennom en kolonne méd vandig, surt magnesiumsilikat. Til utløpet fra tilbakeløpsbehandlingen tilsettes heksan inntil det opptrer krystallisasjon. Produktet oppsamles ved filtrering og tørkes. A mixture of 5.0 g of 3,4-dimethoxypropiophenone, 2.71 g of ethyl carbazate and 2 drops of concentrated hydrochloric acid in 100 ml of 95% ethanol is heated under reflux on a steam bath for 1 hour. The mixture is cooled overnight and evaporated to dryness to give an oil. The oil is triturated with hot hexane so that a crystalline product is obtained. This product is dissolved in methylene chloride and passed through a column with aqueous, acidic magnesium silicate. Hexane is added to the outlet from the reflux treatment until crystallization occurs. The product is collected by filtration and dried.

Analyse: Beregnet for c14H2oN2°4: C'59'48'H' 7'19' N' 9'99 Analysis: Calculated for c14H2oN2°4: C'59'48'H' 7'19' N' 9'99

Funnet C, 59,70, H, 7,52, N, 10,00. Found C, 59.70, H, 7.52, N, 10.00.

Eksempel 12Example 12

Fremstilling av 3-( 3- etoksysalicyliden)- karbazinsyre- etylester Preparation of 3-(3- ethoxysalicylidene)- carbamic acid ethyl ester

En blanding av 4,98 g 3-etoksysalicylaldehyd, 3,12 g etylkarbazat og 2 dråper konsentrert saltsyre i 150 ml 95 %-ig etanol oppvarmes på et dampbad i 1 time og inndampes til tørrhet. Produktet omkrystalliseres fra aceton-heksan to ganger hvorved det oppnås 5,75 g som smelter ved 143-1<!>4'4°C. A mixture of 4.98 g of 3-ethoxysalicylaldehyde, 3.12 g of ethyl carbazate and 2 drops of concentrated hydrochloric acid in 150 ml of 95% ethanol is heated on a steam bath for 1 hour and evaporated to dryness. The product is recrystallized from acetone-hexane twice whereby 5.75 g is obtained which melts at 143-1<!>4'4°C.

Analyse: Beregnet for^c12Hi6N2°4: C'57'13'H, 6,39, N, 11,11 Analysis: Calculated for ^c12Hi6N2°4: C'57'13'H, 6.39, N, 11.11

Funnet : C, 57,25<,>H, 6,34, N, 10,97. Found: C, 57.25<,>H, 6.34, N, 10.97.

Eksempel 13Example 13

Fremstilling av 3-[ 1-( 3- bifenylyl) etyliden]- karbazinsyre- ety1-ester Preparation of 3-[1-(3-biphenylyl)ethylidene]-carbamic acid ethyl ester

En blanding av 2,5 g 3-acetylbifenyl og 2,5 g etylkarbazat i 10 ml absolutt etanol inneholdende 2 dråper konsentrert saltsyre oppvarmes på et dampbad i 3 timer. Vann tilsettes og det dannes en gummi. Denne gummi oppløses i metylenklorid og føres gjennom en kolonne med surt magnejsiumsilikat. Utløpet fra tilbakeløpsoppvarmingen'behandles med heksan til A mixture of 2.5 g of 3-acetylbiphenyl and 2.5 g of ethyl carbazate in 10 ml of absolute ethanol containing 2 drops of concentrated hydrochloric acid is heated on a steam bath for 3 hours. Water is added and a gum is formed. This gum is dissolved in methylene chloride and passed through a column of acidic magnesium silicate. The effluent from the reflux heating is treated with hexane to

dét opptrer krystallisasjon. Metylenkloridsurt magnesiumsilikat-heksan-behandlingen gjentas. Produktet oppsamles ved filtrering, omkrystalliseres fra aceton-heksan og tørkes. Det oppnås 1,30 g som smelter ved 107-107,5°C. crystallization occurs. The methylene chloride acid magnesium silicate-hexane treatment is repeated. The product is collected by filtration, recrystallized from acetone-hexane and dried. 1.30 g is obtained which melts at 107-107.5°C.

Claims (6)

1. Fremgangsmåte for fremstilling av en forbindelse med formelen: 1. Procedure for preparing a compound of the formula: hvor er hydrogen eller lavere alkyl (C^ -Cg), er lavere alkyl (C^ -Cg) og X er 2-naftyl, 3-fenantryl, 5-indanyl, 5,6,7,8-tetrahydro-2-naftyl, 2-benzofuranyl, 5-klor-2-benzofuranyl, 3,4-dimetoksybenzyl, 3-etoksy-2-hydroksybenzyl eller 3-bifenyl, kar afk terisert ved at en forbindelse med formelen: where is hydrogen or lower alkyl (C^ -Cg ), is lower alkyl (C^ -Cg ) and X is 2-naphthyl, 3-phenanthryl, 5-indanyl, 5,6,7,8-tetrahydro-2-naphthyl , 2-benzofuranyl, 5-chloro-2-benzofuranyl, 3,4-dimethoxybenzyl, 3-ethoxy-2-hydroxybenzyl or 3-biphenyl, characterized in that a compound of the formula: hvor R^ og X er som ovenfor definert, omsettes med en karbazin-syreester med formelen: where R^ and X are as defined above, is reacted with a carbazine acid ester of the formula: hvor R2 er som ovenfor definert, i et organisk løsningsmiddel ved tilbakeløpstemperatur og at produktet isoleres derfra.where R2 is as defined above, in an organic solvent at reflux temperature and that the product is isolated therefrom. 2. Fremgangsmåte for fremstilling av en /3-riaftyl- alkyliden-karbazinsyre-ester med formelen: 2. Process for the preparation of a /3-riaphthyl- alkylidene-carbazinic acid ester with the formula: hvor er hydrogen eller lavere alkyl (C^ -C^ ) og R2 er lavere alkyl (C^ -C^ )/karakterisert ved at en forbindelse med formelen: where is hydrogen or lower alkyl (C^ -C^ ) and R 2 is lower alkyl (C^ -C^ )/characterized in that a compound with the formula: hvor R^ er som ovenfor definert, omsettes med en forbindelse med formelen: where R^ is as defined above, is reacted with a compound of the formula: hvor R2 er som ovenfor angitt.where R2 is as indicated above. 3. Fremgangsmåte for fremstilling av en forbindelse med formelen: .. 3. Procedure for the preparation of a compound of the formula: .. hvor R1 er lavere.alkyl (C^-Cg), karakterisert ved at en forbindelse med formelen: where R1 is lower.alkyl (C^-Cg), characterized in that a compound with the formula: omsettes med en forbindelse med formelen: NH2 NHCOOR1 hvorR^ er som ovenfor angitt, i nærvær av HCl som katalysator i et organisk løsningsmiddel, at nevnte blanding oppvarmes ved tilbakeløpstemperatur fra 1 til 2 timer og at nevnte produkt isoleres derfra.is reacted with a compound with the formula: NH2 NHCOOR1 where R^ is as indicated above, in the presence of HCl as a catalyst in an organic solvent, that said mixture is heated at reflux temperature from 1 to 2 hours and that said product is isolated therefrom. 4. Fremgangsmåte for fremstilling av en forbindelse med formelen: 4. Procedure for the preparation of a compound of the formula: hvor R2 er lavere alkyl (C^-Cg) og X er 1 eller 2, karakterisert ved at en forbindelse med formelen: where R 2 is lower alkyl (C 2 -C 8 ) and X is 1 or 2, characterized in that a compound with the formula: hvor X er som ovenfor angitt, omsettes med en forbindelse med formelen: where X is as indicated above, is reacted with a compound of the formula: hvor R2 er som ovenfor angitt, i nærvær av HCl og etanol og at nevnte reaksjonsblanding oppvarmes ved tilbakeløpstemperatur i 1 til 2 timer og at nevnte produkt isoleres derfra.where R2 is as stated above, in the presence of HCl and ethanol and that said reaction mixture is heated at reflux temperature for 1 to 2 hours and that said product is isolated therefrom. 5. Fremgangsmåte for fremstilling av en forbindelse med formelen: 5. Procedure for the preparation of a compound of the formula: hvor R er hydrogen eller klor og R2 er a <r> lkyl (C^-C^) / karakterisert ved at en forbindelse med formelen: where R is hydrogen or chlorine and R2 is alkyl (C^-C^) / characterized in that a compound with the formula: hvor R er som ovenfor angitt, omsettes med en forbindelse med formelen: where R is as indicated above, is reacted with a compound of the formula: hvor R2 er som ovenfor angitt, i nærvær av etanol og saltsyre ved tilbakeløpstemperatur i 1 til 2 timer og at nevnte produkt isoleres derfra.where R2 is as stated above, in the presence of ethanol and hydrochloric acid at reflux temperature for 1 to 2 hours and that said product isolated from there. 6. Fremgangsmåte for fremstilling av en forbindelse meli formelen: 6. Procedure for the preparation of a compound of the formula: hvor" R4 er hydrogen eller metoksy, R^ er metoksy, etoksy, eller fenyl, R^ er hydrogen eller hydroksy og R^ er hydrogen, metyl eller etyl, karakterisert ved at en forbindelse med formelen: where" R4 is hydrogen or methoxy, R^ is methoxy, ethoxy, or phenyl, R^ is hydrogen or hydroxy and R^ is hydrogen, methyl or ethyl, characterized in that a compound with the formula: hvor R^ , R,-, Rg og R^ er som ovenfor angitt, omsettes med enwhere R^ , R1-, Rg and R^ are as indicated above, is converted to a
NO744537A 1973-12-17 1974-12-16 NO744537L (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US00425421A US3855276A (en) 1973-12-17 1973-12-17 Phenanthryl ethylidene carbazic acid esters
US00425422A US3852334A (en) 1973-12-17 1973-12-17 Substituted carbazic acid esters
US00425420A US3856838A (en) 1973-12-17 1973-12-17 Beta-naphthyl alkylidene carbazic acid esters
US425423A US3882149A (en) 1973-12-17 1973-12-17 Substituted benzofuranyl ethylidene carbazic acid esters

Publications (1)

Publication Number Publication Date
NO744537L true NO744537L (en) 1975-07-14

Family

ID=27503727

Family Applications (1)

Application Number Title Priority Date Filing Date
NO744537A NO744537L (en) 1973-12-17 1974-12-16

Country Status (11)

Country Link
JP (1) JPS50116448A (en)
AR (1) AR203665A1 (en)
AU (1) AU7584974A (en)
DD (1) DD118419A5 (en)
DE (1) DE2455684A1 (en)
DK (1) DK648774A (en)
FR (1) FR2254328A1 (en)
IL (1) IL46086A0 (en)
NO (1) NO744537L (en)
RO (1) RO71805A (en)
SE (1) SE7415800L (en)

Also Published As

Publication number Publication date
FR2254328B1 (en) 1977-11-04
AR203665A1 (en) 1975-09-30
DE2455684A1 (en) 1975-06-19
AU7584974A (en) 1976-06-03
SE7415800L (en) 1975-06-18
IL46086A0 (en) 1975-03-13
DK648774A (en) 1975-08-25
DD118419A5 (en) 1976-03-05
RO71805A (en) 1982-02-26
FR2254328A1 (en) 1975-07-11
JPS50116448A (en) 1975-09-11

Similar Documents

Publication Publication Date Title
DE69219394T2 (en) Heterocyclic alkylamides, processes for their preparation and pharmaceutical preparations containing them
Adams et al. Ultraviolet spectra and structures of the pyrido [1, 2-a] pyrimidones
CH626612A5 (en)
EP0019081A1 (en) Flavone derivatives, their preparation, these novel and known flavones as antiviral agents, and pharmaceutical compositions containing them
Rodig et al. Pyridine Chemistry. I. The Smiles Rearrangement of the 3-Amino-2, 2'-dipyridyl Sulfide System1
Magnus et al. The pyridylethylation of active hydrogen compounds. V. The reaction of ammonia, certain amines, amides and nitriles with 2-and 4-vinylpyridine and 2-methyl-5-vinylpyridine1
Baumgarten et al. Cinnolines. VI. The Structure of Neber's Lactam. A New Synthesis of 3-Cinnolinol1, 2
US5550280A (en) Hindered aromatic ester compounds useful as anti-viral agents
Rice et al. Spiranes. III. 1a, b Azaspiranes and Intermediates1c
US4714764A (en) 2-(4-pyridylaminomethyl)-benzimidazole derivatives having antiviral activity
US3139441A (en) Alpha (3, 4 dihidroxy phenyl)-beta-(nu-3, 14&#39;-methylenedioxy-phenyl)-alkylamino ethanols
NO744537L (en)
Heymann et al. Derivatives of p, p'-Diaminodiphenyl Sulfone1a
KR20000048767A (en) N-benzothiazol-2-yl)piperidine-1-ethanamine derivatives, their preparation and application in therapeutics
US3882123A (en) 2,5-Bis-substituted amino-1,3,4-thiadiazoles and method of use
Shaw et al. Analogs of Aspergillic Acid. III. Synthesis of Cyclic Hydroxamic Acids with a Five-membered Ring
Gadekar et al. Synthesis and biological activity of pyridoxine analogs
BARONE et al. A 2-Trifluoromethyl Analog of Thiamin1
JPS6015616B2 (en) Method for producing N-2-(pyrrolidinylmethyl)-substituted benzamide derivative or salts thereof
Koelsch The reaction of benzylmagnesium chloride with 3-phenylquinazolone-4
Burckhalter et al. Esters of α-(2-Dialkylaminoethyl)-benzyl Alcohols
US3812135A (en) Pyrroloindole and pyridoindole derivatives
Baker et al. AN ANTIMALARIAL ALKALOID FROM HYDRANGEA. V. SOME 3-(β-KETO-sec-AMINOALKYL)-4-QUINAZOLONES
WALTERS et al. Condensation of Isocyanates with Reissert Compounds; Synthesis of an Analog of Lidocaine
CN102971301A (en) 6 - methyl - 4 - phenyl - 5 - ( phenyl or cycloalkyl) carbamoyl - 1,2,3, 4 - tetrahydropyrimidin- 2 - one derivatives as antitubercular agents